Huoxiang Zhengqi For Covid 19 Market Report 2026

Huoxiang Zhengqi For Covid 19 Market Overview

• Huoxiang Zhengqi For Covid 19 market size has reached to $1.54 billion in 2025 • Expected to grow to $2.72 billion in 2030 at a compound annual growth rate (CAGR) of 12.1% • Growth Driver: Increasing Demand For Herbal Medicine Fueling The Growth Of The Market Due To Consumer Preference For Natural Remedies • Market Trend: Innovative Private-Brand Formulation Launches Enhance Product Accessibility • Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Huoxiang Zhengqi For Covid 19 Market?

Huoxiang Zhengqi for COVID-19 is a traditional Chinese herbal formula used to treat COVID-19 cases, particularly where symptoms involve gastrointestinal issues such as nausea, diarrhea, or fatigue due to dampness. Its primary purpose in this context is to expel dampness, relieve exterior syndromes, and support digestive and immune function. It is often combined with antiviral and supportive therapies in traditional Chinese medicine protocols. The main types of huoxiang zhengqi for COVID-19 include liquid, pills, granules, and other variants. huoxiang zhengqi Liquid is a traditional Chinese herbal remedy designed to alleviate digestive issues such as nausea, vomiting, and bloating by balancing the stomach and spleen. Its consumers are typically health-conscious individuals, those seeking immune system support, alternative medicine supporters, and parents buying for their children. It is commonly used for preventive health, during COVID-19 symptoms, post-recovery health management, as well as for seasonal and illness-related protection. It is suitable for use in hospitals, clinics, home care settings, and other environments. The various applications include hospitals, clinics, home care, and other settings.

What Is The Huoxiang Zhengqi For Covid 19 Market Growth Forecast?

The huoxiang zhengqi for covid 19 market size is expected to see rapid growth in the next few years. It will grow to $2.72 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to continued interest in immune-support therapies, expansion of integrative medicine practices, rising health-conscious consumer base, growth of herbal pharmaceutical manufacturing, increasing research into traditional formulations. Major trends in the forecast period include growing acceptance of traditional chinese medicine, increasing use of herbal formulations for immune support, expansion of preventive healthcare applications, rising integration with conventional covid therapies, increasing demand for digestive and immune health remedies.

Global Huoxiang Zhengqi For Covid 19 Market Segmentation

1) By Product Type: Liquid, Pills, Granules, Other Product Types 2) By Consumers: Health-Conscious Consumers, Individuals Seeking Immunity Support, Alternative Medicine Enthusiasts, Parents Purchasing For Children 3) By Usage Occasions: Preventive Health Use, During COVID 19 Symptoms, Post-Recovery Health Management, Seasonal Illness Protection 4) By Application: Hospitals, Clinics, Home Care, Other Applications 5) By Distribution Chanel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Chanels Subsegments: 1) By Liquid: Oral Liquid, Injectable Liquid 2) By Pills: Tablets, Capsules 3) By Granules: Single-Dose Granules, Multi-Dose Granules 4) By Other Product Types: Syrup, Powder For Solution

What Is The Driver Of The Huoxiang Zhengqi For Covid 19 Market?

The increasing demand for herbal medicine is expected to propel the growth of the Huoxiang Zhengqi for COVID-19 market going forward. Herbal medicine refers to the use of plants or plant-derived substances for therapeutic or medicinal purposes to prevent, treat, or manage health conditions. The rising demand for herbal medicine is mainly driven by consumers' growing preference for natural, plant-based remedies over synthetic drugs due to perceived safety, fewer side effects, and holistic health benefits. Huoxiang Zhengqi for COVID-19 aids herbal medicine by providing a traditional remedy that supports immune function, alleviates symptoms, and promotes recovery, demonstrating the potential role of herbal therapies in managing viral infections. For instance, in September 2024, according to the HerbalGram, a US-based nonprofit organization, the total annual sales of herbal dietary supplements rose from $12.018 billion in 2022 to $12.551 billion in 2023, reflecting a growth of 4.4%. Therefore, the increasing demand for herbal medicine is driving the growth of the Huoxiang Zhengqi for COVID-19 market.

Key Players In The Global Huoxiang Zhengqi For Covid 19 Market

Major companies operating in the huoxiang zhengqi for covid 19 market are Yunnan Baiyao Group Co. Ltd., Beijing Tongrentang Co. Ltd., Taiji Group Chongqing Fuling Pharmaceutical Factory Co. Ltd., Tasly Pharmaceutical Group Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., Guizhou Sanli Pharmaceutical Co. Ltd., China Shineway Pharmaceutical Group Limited, Zhangzhou Pientzehuang Pharmaceutical Co. Ltd., Wuhu Zhanghengchun Medicine Co. Ltd., Tonghua Dongbao Pharmaceutical Co. Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd., Sichuan Neo-Green Pharmaceutical Technology Co. Ltd., Hutchison China MediTech Limited, Shijiazhuang Yiling Pharmaceutical Co. Ltd., Jilin Aodong Pharmaceutical Group Co. Ltd., Livzon Pharmaceutical Group Inc., China Traditional Chinese Medicine Holdings Co. Ltd., Kunming Pharmaceutical Corp., Guangdong Yifang Pharmaceutical Co. Ltd., Jiangyin Tianjiang Pharmaceutical Co. Ltd.

Global Huoxiang Zhengqi For Covid 19 Market Trends and Insights

Major companies operating in the Huoxiang Zhengqi for COVID-19 market are focusing on innovative private-brand formulation launches, such as Huoxiang Zhengqi oral liquid products, which are modernized liquid preparations of the traditional Huoxiang Zhengqi herbal formula designed to improve convenience, dosage accuracy, and rapid absorption. For instance, in June 2024, YSB Inc., a China-based pharmaceutical retail and healthcare services company, introduced the Leyaoshi Huoxiang Zhengqi Oral Liquid. The product featured a ready-to-drink single-dose liquid format, rapid-onset digestive and anti-dampness support, and a formulation optimized for seasonal gastrointestinal discomfort.

What Are Latest Mergers And Acquisitions In The Huoxiang Zhengqi For Covid 19 Market?

In August 2024, China Resources Sanjiu, a China-based provider of traditional Chinese medicines and pharmaceutical products, acquired 28% of Tasly Pharmaceuticals for USD 8.75 billion (RMB 62.12 billion). With this acquisition, the company aimed to significantly bolster its control over Tasly, enhancing its strategic capacity in modern Chinese medicine innovation and integrated drug development. Tasly Pharmaceuticals is a China-based provider of modern traditional Chinese medicines, chemical drugs, and biopharmaceutical therapies.

Regional Insights

Asia-Pacific was the largest region in the Huoxiang Zhengqi for COVID-19 market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Huoxiang Zhengqi For Covid 19 Market?

The huoxiang Zhengqi for COVID-19 market consists of sales of syrups, powders, injections, essential oils, and nasal sprays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Huoxiang Zhengqi For Covid 19 Market Report 2026?

The huoxiang zhengqi for covid 19 market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the huoxiang zhengqi for covid 19 industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.